Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Judge: Walgreens contributed to San Francisco opioid crisis

A federal judge has ruled that Walgreens can be held responsible for contributing to San Francisco’s opioid crisis for over-dispensing opioids for years without proper oversight and failing to identify and report suspicious orders as required by law

The Independent UK

Walgreens played ‘substantial’ role in San Francisco opioid crisis, judge finds

The pharmacy chain failed to properly investigate suspicious opioid orders, according to federal ruling

The Guardian - US

1 Biotech Stock Investors Will Want to Buy This Week

Gilead Sciences (GILD), a biopharmaceutical company, reported strong demand across its HIV portfolio and raised its full-year guidance. Given the company’s robust profitability and discounted valuation, we think it could be wise to buy the stock now. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Exclusive-Rotavirus childhood vaccine shortage hits four African countries

Supplies of a vaccine to prevent the deadly rotavirus infection in children have either run out in Kenya, Tanzania, Senegal and Cameroon or are close to doing so, officials close to the roll-out told Reuters, after disruptions at drugmaker GSK.

Reuters

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Benzinga

CORBEVAX booster shot approved for 18 years and above jabbed with Covaxin, Covishield

Corbevax booster for heterologous first has been approved by the Centre.Last month the National Technical Advisory Group on Immunisation (NTAGI) recommended Biological E's CORBEVAX as a heterologous booster for adults above 18 yrs old. Read more on Dynamite News:

Dynamite News

White House announces steps to boost monkeypox vaccine supply

The FDA has issued emergency authorisation for a dosage technique that would allow more shots of vaccine per vial.

Al Jazeera

Read news from The Economist, FT, and more,
with one subscription

Recap of Tuesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

Benzinga

Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups

Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights advocacy groups craft public health responses to monkeypox outbreaks, the company said.

Reuters

Key leprosy drug shortage in India is not of recent origin

Pharmaceutical pricing authority discussed issue in 2019, show documents

The Hindu

France to launch pilot vaccination scheme against monkeypox

Four French pharmacies will be authorised to vaccinate against monkeypox from Wednesday, according to the office of Health Minister François Braun.

Radio France Internationale

Pfizer's Perth employees strike over pay

Pharmaceutical giant Pfizer is facing calls to improve its pay offer to manufacturing employees in Perth, who have walked off the job.

AAP

Trial seeks to develop first Lyme disease vaccine in 2 decades

The only Lyme disease vaccine previously marketed in the U.S. was discontinued in 2002.

Axios

2 Pharmaceutical Stocks That Could Outperform the Market in the Long Term

The pharmaceutical industry is growing rapidly with advancements in drug manufacturing and a paradigm shift to personalized medicines. Moreover, despite soaring prices, supportive fiscal policies are expected to keep consumer demand stable. Quality pharmaceutical stocks Pfizer (PFE) and Merck (MRK) have outperformed the broader market over the past year and…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

Blackmores subsidiary kept selling pregnancy vitamins despite hundreds of complaints, ex-employee alleges

Whistleblower says he was instructed to tell customers the products were safe to consume, despite lack of testing evidence

Reuters

U.S. slams China's 'unacceptable' disruption in countering fentanyl

China's move to suspend cooperation with the United States to combat narcotics trafficking, including illicit fentanyl, is "unacceptable," the White House said on Monday, as Beijing continued to protest a visit to Taiwan by U.S. House Speaker Nancy Pelosi.

The Independent UK

BioNTech reports strong first half, expects demand to grow

BioNTech, which teamed with Pfizer to develop the first widely used COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year

The Independent UK

Republicans condemned for striking down insulin cap in major Biden legislation: ‘Shame on you’

‘How many people have to die from insulin rationing before they stop blocking action?’

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

LEXX: Put Your Drinks Up! Four Deals Signed in June

By John Vandermosten, CFA NASDAQ:LEXX READ THE FULL LEXX RESEARCH REPORT

Bristol Post

East Bristol has lost most pharmacies in England since 2016

And there are concerns that more pharmacies could close soon

Reuters

Climate change puts Lyme disease in focus for France's Valneva after COVID blow

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

Chicago Sun-Times

Another reason not to work in Indiana

Eli Lilly and Co. was quick to understand just how bad a near abortion ban can be on business.

Daily Mirror

Fears of 'chemist deserts' in areas where a third of pharmacies have shut in six years

New data reveals Bristol East, Bradford West, Pendle, Torbay and Hove are among the areas to have lost the largest numbers of pharmacies in the last few years

The Independent UK

COVID-19 vaccine sales push Moderna past expectations in Q2

Better-than-expected COVID-19 vaccine sales pushed Moderna past Wall Street’s second-quarter forecasts

The Guardian - UK

Haleon’s debut suggests it may not be the jewel in GSK’s medicine cabinet

Consumer goods spin-off makes few waves in biggest European listing for more than a decade

1 … 140 141 142 143

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

348 stories

PFE

346 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.